Galapagos NV
GLPG
#4540
Rank
ยฃ1.63 B
Marketcap
ยฃ24.77
Share price
-0.73%
Change (1 day)
33.40%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2025 (TTM): -ยฃ0.4 Billion

According to Galapagos NV's latest financial reports the company's current earnings are ยฃ0.32 Billion. In 2024 the company made an earning of -ยฃ4.23 Million, an increase over its 2023 earnings that were of -ยฃ24.52 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ0.4 Billion9325.59%
2024 -ยฃ4.23 Million-82.77%
2023 -ยฃ24.52 Million-85.59%
2022 -ยฃ0.18 Billion60.71%
2021 -ยฃ0.11 Billion-60.08%
2020 -ยฃ0.27 Billion-331.44%
2019 ยฃ0.11 B-523.76%
2018 -ยฃ27.05 Million-72.34%
2017 -ยฃ97.81 Million-329.59%
2016 ยฃ42.59 M-144.3%
2015 -ยฃ96.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ23.68 B-6,184.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ5.94 B-1,628.56%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ1.21 B-411.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ6.65 B-1,809.31%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
ยฃ16.87 B-4,437.01%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ9.56 B-2,558.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ6.81 B-1,851.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-ยฃ39.09 Million-89.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.29 B-432.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel